Mesa Laboratories, Inc. (MLAB)
NASDAQ: MLAB · Real-Time Price · USD
141.70
-4.20 (-2.88%)
Feb 21, 2025, 4:00 PM EST - Market closed
Mesa Laboratories Income Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 237.75 | 216.19 | 219.08 | 184.34 | 133.94 | 117.69 | Upgrade
|
| Revenue Growth (YoY) | 11.68% | -1.32% | 18.85% | 37.63% | 13.81% | 14.11% | Upgrade
|
| Cost of Revenue | 86.27 | 81.71 | 85.39 | 75.25 | 46.92 | 52.33 | Upgrade
|
| Gross Profit | 151.48 | 134.48 | 133.69 | 109.09 | 87.01 | 65.36 | Upgrade
|
| Selling, General & Admin | 111.27 | 111.49 | 109.88 | 88.62 | 64.27 | 51.08 | Upgrade
|
| Research & Development | 19.62 | 19.3 | 20.49 | 15.77 | 10.39 | 6.36 | Upgrade
|
| Operating Expenses | 130.9 | 130.79 | 130.37 | 104.39 | 74.66 | 57.44 | Upgrade
|
| Operating Income | 20.58 | 3.69 | 3.32 | 4.7 | 12.36 | 7.92 | Upgrade
|
| Interest Expense | -11.23 | -5.7 | -4.77 | -3.89 | -8.02 | -5.5 | Upgrade
|
| Other Non Operating Income (Expenses) | -5.07 | 2.12 | 1.06 | 2.76 | -2.03 | 1.44 | Upgrade
|
| EBT Excluding Unusual Items | 4.28 | 0.11 | -0.39 | 3.57 | 2.3 | 3.86 | Upgrade
|
| Merger & Restructuring Charges | -2.46 | -1.23 | - | - | - | - | Upgrade
|
| Impairment of Goodwill | -156.89 | -156.89 | - | - | - | - | Upgrade
|
| Asset Writedown | -117.64 | -117.64 | - | - | - | - | Upgrade
|
| Other Unusual Items | 2.89 | - | - | - | - | - | Upgrade
|
| Pretax Income | -269.83 | -275.65 | -0.39 | 3.57 | 2.3 | 3.86 | Upgrade
|
| Income Tax Expense | -20.39 | -21.4 | -1.32 | 1.7 | -0.97 | 2.08 | Upgrade
|
| Net Income | -249.44 | -254.25 | 0.93 | 1.87 | 3.27 | 1.78 | Upgrade
|
| Net Income to Common | -249.44 | -254.25 | 0.93 | 1.87 | 3.27 | 1.78 | Upgrade
|
| Net Income Growth | - | - | -50.29% | -42.85% | 84.14% | -76.24% | Upgrade
|
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 4 | Upgrade
|
| Shares Change (YoY) | 0.31% | 0.47% | 0.49% | 4.12% | 17.23% | 8.38% | Upgrade
|
| EPS (Basic) | -46.13 | -47.20 | 0.17 | 0.36 | 0.66 | 0.42 | Upgrade
|
| EPS (Diluted) | -46.13 | -47.20 | 0.17 | 0.35 | 0.64 | 0.41 | Upgrade
|
| EPS Growth | - | - | -51.43% | -45.31% | 56.10% | -77.96% | Upgrade
|
| Free Cash Flow | 43 | 41.57 | 23.44 | 34.79 | 35.08 | 25.49 | Upgrade
|
| Free Cash Flow Per Share | 7.95 | 7.72 | 4.37 | 6.52 | 6.85 | 5.83 | Upgrade
|
| Dividend Per Share | 0.640 | 0.640 | 0.640 | 0.640 | 0.640 | 0.640 | Upgrade
|
| Gross Margin | 63.71% | 62.20% | 61.02% | 59.18% | 64.97% | 55.54% | Upgrade
|
| Operating Margin | 8.65% | 1.71% | 1.52% | 2.55% | 9.23% | 6.73% | Upgrade
|
| Profit Margin | -104.92% | -117.60% | 0.42% | 1.01% | 2.44% | 1.51% | Upgrade
|
| Free Cash Flow Margin | 18.09% | 19.23% | 10.70% | 18.87% | 26.19% | 21.66% | Upgrade
|
| EBITDA | 43.9 | 35.26 | 36.45 | 29.77 | 30.02 | 20.91 | Upgrade
|
| EBITDA Margin | 18.47% | 16.31% | 16.64% | 16.15% | 22.41% | 17.77% | Upgrade
|
| D&A For EBITDA | 23.33 | 31.57 | 33.13 | 25.07 | 17.66 | 12.99 | Upgrade
|
| EBIT | 20.58 | 3.69 | 3.32 | 4.7 | 12.36 | 7.92 | Upgrade
|
| EBIT Margin | 8.65% | 1.71% | 1.52% | 2.55% | 9.23% | 6.73% | Upgrade
|
| Effective Tax Rate | - | - | - | 47.65% | - | 53.96% | Upgrade
|
| Revenue as Reported | 216.19 | 216.19 | 219.08 | 184.34 | 133.94 | 117.69 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.